{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:20Z","timestamp":1761991820683,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ijcard.2016.06.018","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T06:28:53Z","timestamp":1466058533000},"page":"350-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on left ventricular mass index and ejection fraction in hemodialysis patients: A meta-analysis with trial sequential analysis of randomized controlled trials"],"prefix":"10.1016","volume":"219","author":[{"given":"Yue","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-ge","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1 Suppl 1","key":"10.1016\/j.ijcard.2016.06.018_bb0005","first-page":"S1","article-title":"Excerpts from the United States Renal Data System 2007 annual data report","volume":"51","author":"Collins","year":"2008","journal-title":"Am. J. Kidney Dis."},{"issue":"17","key":"10.1016\/j.ijcard.2016.06.018_bb0010","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ijcard.2016.06.018_bb0015","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1111\/j.1523-1755.2004.00657.x","article-title":"Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study","volume":"65","author":"Cheung","year":"2004","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.ijcard.2016.06.018_bb0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000184887","article-title":"Left ventricular hypertrophy in end-stage renal disease","volume":"48","author":"Harnett","year":"1988","journal-title":"Nephron"},{"issue":"16","key":"10.1016\/j.ijcard.2016.06.018_bb0025","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.ijcard.2016.06.018_bb0030","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2016.06.018_bb0035","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2215\/CJN.07831109","article-title":"Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis","volume":"5","author":"Tai","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"author":"Higgins","key":"10.1016\/j.ijcard.2016.06.018_bb0040"},{"key":"10.1016\/j.ijcard.2016.06.018_bb0045","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2016.06.018_bb0050","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"7650","key":"10.1016\/j.ijcard.2016.06.018_bb0055","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7414","key":"10.1016\/j.ijcard.2016.06.018_bb0060","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7109","key":"10.1016\/j.ijcard.2016.06.018_bb0065","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ijcard.2016.06.018_bb0070","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.ijcard.2016.06.018_bb0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"J. Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.ijcard.2016.06.018_bb0080","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00005344-200403000-00008","article-title":"Angiotensin receptor antagonist regresses left ventricular hypertrophy associated with diabetic nephropathy in dialysis patients","volume":"43","author":"Kanno","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijcard.2016.06.018_bb0085","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1161\/01.CIR.90.6.2786","article-title":"Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade","volume":"90","author":"London","year":"1994","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2016.06.018_bb0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1291\/hypres.29.253","article-title":"Effects of imidapril on left ventricular mass in chronic hemodialysis patients","volume":"29","author":"Matsumoto","year":"2006","journal-title":"Hypertens. Res."},{"issue":"1","key":"10.1016\/j.ijcard.2016.06.018_bb0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.atherosclerosis.2009.04.005","article-title":"Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis","volume":"207","author":"Mitsuhashi","year":"2009","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.ijcard.2016.06.018_bb0100","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ki.2014.69","article-title":"No significant effect of angiotensin II receptor blockade on intermediate cardiovascular end points in hemodialysis patients","volume":"86","author":"Peters","year":"2014","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.ijcard.2016.06.018_bb0105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000049060","article-title":"Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease","volume":"90","author":"Shibasaki","year":"2002","journal-title":"Nephron"},{"issue":"8","key":"10.1016\/j.ijcard.2016.06.018_bb0110","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3109\/0886022X.2010.502276","article-title":"Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients","volume":"32","author":"Yilmaz","year":"2010","journal-title":"Ren. Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2016.06.018_bb0115","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.ajkd.2005.11.024","article-title":"Effect of ramipril on left ventricular mass in normotensive hemodialysis patients","volume":"47","author":"Yu","year":"2006","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.ijcard.2016.06.018_bb0120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ki.1995.22","article-title":"Clinical and echocardiographic disease in patients starting end-stage renal disease therapy","volume":"47","author":"Foley","year":"1995","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.ijcard.2016.06.018_bb0125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.1989.192","article-title":"Impact of left ventricular hypertrophy on survival in end-stage renal disease","volume":"36","author":"Silberberg","year":"1989","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.ijcard.2016.06.018_bb0130","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/ndt\/13.6.1489","article-title":"Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs","volume":"13","author":"Ozkahya","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.ijcard.2016.06.018_bb0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-1797.2004.00260.x","article-title":"Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: what is the evidence?","volume":"9","author":"Wang","year":"2004","journal-title":"Nephrology (Carlton)"},{"issue":"17","key":"10.1016\/j.ijcard.2016.06.018_bb0140","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJM199904293401704","article-title":"Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure","volume":"340","author":"Ligtenberg","year":"1999","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731631021X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731631021X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T06:24:15Z","timestamp":1536647055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752731631021X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":28,"alternative-id":["S016752731631021X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.018","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on left ventricular mass index and ejection fraction in hemodialysis patients: A meta-analysis with trial sequential analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}